WKRC: Local researchers working on a new potential way to treat eye diseases

UC led research may soon have a new kinder, gentler way to treat eye diseases.

UC drug delivery researcher Kevin Li, a professor in the James L. Winkle College of Pharmacy, takes the lead on new research looking for different ways to treat eye diseases such as macular degeneration and diabetic retinopathy. Currently, these diseases are treated with direct eye injections.

In an interview with WKRC, co-researcher Michael Yang, a pediatric ophthalmologist at Cincinnati Children’s Hospital Medical Center, explains how this federally funded study will seek alternatives to current drug delivery methods.  

The study is a collaboration between UC, CCHMC and Ohio State University.

View the WKRC interview.

Read more about the study.

Featured image at top of eye. Photo/Victor Freitas/unsplash.

 

Impact Lives Here

The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.

Related Stories

2

UC researchers secure seven-figure contract from Department of...

November 19, 2024

Launched in 2017 as one of the first initiatives funded by the University of Cincinnati’s Technology Accelerator for Commercialization (now the UC Venture Lab), Sense Neuro Diagnostics, a MedTech startup, has secured a $2 million contract from the United States Department of Defense, the Cincinnati Business Courier reported.

3

UC celebrates first-generation college students throughout...

November 19, 2024

Students and administrators speak with WLWT, Channel 5, about first-generation college students at the University of Cincinnati. UC is waiving its application fee for all undegraduate programs throughout November. The move is to encourage more first-gen students to consider higher education.

Debug Query for this